#ESMO Archives - MediaMedic

🔬 Deciphering the Future of RCC Treatment: Prof. Manuela Schmidinger on LITESPARK Studies and HIF-2α Inhibitors

By Mourabit Halima 2023.12.20

At the recent European Society for Medical Oncology (ESMO) conference, a critical spotlight was on the groundbreaking results of the LITESPARK-003 and LITESPARK-005 studies. Understanding the implications of these studies…

🔬 Highlighting TAR-200: Prof. Andrea Necchi’s Perspective on Cancer Treatment Advances

By Lisa Cui 2023.12.20

Oncology Frontier brings you an insightful overview of the TAR-200 delivery system, a promising development in cancer therapy, through the lens of Professor Andrea Necchi's expertise. As a distinguished figure…

🔬 Navigating Advanced Prostate Cancer: A Deep Dive with Dr. Silke Gillessen

By Peter W. PENG 2023.12.20

In the complex and evolving landscape of oncology, understanding advanced prostate cancer is crucial. To shed light on this significant topic, Oncology Frontier had the privilege of interviewing Dr. Silke…